Navigation Links
Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
Date:11/15/2011

TUSTIN, Calif., Nov. 15, 2011 /PRNewswire/ -- On November 14, 2011, DHS Holding Co. (DHS) issued a press release announcing it will enter into preliminary talks with Radient Pharmaceuticals Corporation (OTCQX:RXPC) (OTCPK:RXPC), to discuss business opportunities that would benefit both parties.  However, that press release was issued without our approval and we do not intend to have any further discussions, or enter into any business opportunities with DHS.

On today's date, our attorneys requested DHS to immediately retract the press release at issue.

The following table is intended to provide the latest information on Radient's business metrics.Radient's Business MetricsCash on hand: $54,000*

*Approximate amount as of November 15, 2011Common Shares Outstanding:  746 million*

*Approximate number as of November 15, 2011.

  5 billion shares authorized.Outstanding Warrants & Options:  110 million*

*Approximate number as of  November 15, 2011About Radient Pharmaceuticals:Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is dedicated to saving lives and money for patients and global healthcare systems through the deployment of its FDA-cleared In Vitro Diagnostic Onko-Sure® cancer test kit for colorectal cancer treatment and recurrence monitoring. The Company's focus is on the discovery, development and commercialization of unique high-value diagnostic tests that will help physicians answer important clinical questions related to early disease state detection, treatment strategy, and the monitoring of disease progression or recurrence. To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com.

Forward-Looking Statements:Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predic
'/>"/>

SOURCE Radient Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Radient Pharmaceuticals Announces FY 2011 Third Quarter Results
2. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
3. Radient Pharmaceuticals Corporation Joins OTCQX
4. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
5. The Outlook for Pharmaceuticals in South East Asia
6. The Outlook for Pharmaceuticals in Western Europe
7. The Outlook for Pharmaceuticals in Central & Eastern Europe
8. The Outlook for Pharmaceuticals in the Middle East and North Africa
9. The Outlook for Pharmaceuticals in Brazil, Russia, India & China
10. The Outlook for Pharmaceuticals in Latin America
11. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... XRpro Sciences, Inc., a provider of ... services which features high throughput transporter and ion ... results for the year ended December 31, 2014. ... XRpro Sciences commented, "We have completed a number ... to commercial stage in large part by achieving ...
(Date:3/27/2015)... -- Report Details  New study ... What does the future hold for top ... brand new report shows you potential revenues to 2025, ... Our 242-page report provides 185 tables, charts, and graphs. ... the future market prospects. Our new study lets you ...
(Date:3/27/2015)... -- According to a new market research ... Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, ... - Global Forecasts to 2019 ", published by MarketsandMarkets, the ... Billion by 2019 with a CAGR of around 10.3% ... Browse   90   ma rket data ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... 2011 US-based Life Technologies Corporation (Nasdaq: ... science solutions, announced today that it has launched a ... demand in the Asia Pacific regions of India, China, ... New Zealand. (Logo:   http://photos.prnewswire.com/prnh/20110216/MM49339LOGO ) ...
... GlaxoSmithKline (NYSE: GSK ) today announced that ... full approval for PROMACTA® (eltrombopag), an oral tablet that ... blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) who ... splenectomy. PROMACTA initially received FDA orphan ...
Cached Medicine Technology:Life Technologies Launches Asia Distribution Center in Singapore 2Life Technologies Launches Asia Distribution Center in Singapore 3Life Technologies Launches Asia Distribution Center in Singapore 4FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 2FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 3FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder 4
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site ... their Las Vegas warehouse, located at 4606 Andrews St. Suite ... of equipment from hospitals and surgery centers from around the ... , Buyers will find items of all types including anesthesia, ... said Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Lately the student-athlete experience has undergone ... around the NCAA. In a March episode of ... a spectrum of universities and sports shed light on ... panel consists of athletes who have competed for universities ... and field, baseball, and volleyball. They discuss the value ...
(Date:3/28/2015)... 2015 Designers and Professionals of ... Scratches 5K from Pixel Film Studios. , “Scratches 5K ... media inside Final Cut Pro X” Said Christina Austin, ... and is an effective tool for any FCPX editor.” ... 5K's intuitive grunge overlays. Simply drag title layers into ...
Breaking Medicine News(10 mins):Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2
... GENCO Supply Chain Solutions, company, to present, ... during U.S. Environmental Protection Agency,s (Region III) Pharmaceutical ... ... Capital Returns, Inc. (CRI), the,pharmaceutical industry,s leading processor of ...
... WALNUT CREEK, Calif., June 5 Longs Drug,Stores Corporation (NYSE: LDG ) today reported preliminary total retail drug,store sales for the four-week and seventeen-week periods ended ... Periods ended ... ... (4 weeks) (17 weeks), Total retail drug ...
... OSHA ,Star Site, PITTSBURGH, June 5 ... Cranberry, Pa. manufacturing plant has been designated a,national ... Occupational,Safety and Health Administration (OSHA). Fewer than 85 ... the U.S. have earned,this distinction since the VPP ...
... Closer Look at The Value of,MRIs is now ... website, http://www.msassociation.org . This three part video,features: ... first-hand,account on the experience of undergoing an MRI; ... the importance of MRIs to monitor disease,progression; and ...
... Awarded Top Juice Beverage by Health Magazine, SEATTLE, ... and,juice producers, and its Yellow Mango Orchard natural 100 ... Buys in 2008 by Health,Magazine., With the help ... products in beauty, food and fitness to the ultimate ...
... 5 Benchmarking is not a luxury;,it is an ... research,excerpt presents a survey analysis of 30 companies and ... are using benchmarking in a,difficult economy., The complete ... to benchmark, the goals of benchmarking studies, how companies ...
Cached Medicine News:Health News:Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:MSA Cranberry Plant Named One of Safest in Country 2Health News:MSA Cranberry Plant Named One of Safest in Country 3Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2
... (IGF-II) is a 7.5 kDa peptide which is ... to have mitogenic and metabolic actions involved in ... by binding to target cell receptors. IGF-II binds ... receptor, a monomeric protein which also serves as ...
... growth factor II (IGF-II) is a 7.5 kDa ... and is postulated to have mitogenic and metabolic ... IGF-II are mediated by binding to target cell ... Type II IGF receptor, a monomeric protein which ...
... growth factor II (IGF-II) is a 7.5 kDa ... and is postulated to have mitogenic and metabolic ... IGF-II are mediated by binding to target cell ... Type II IGF receptor, a monomeric protein which ...
... (PAPP-A) is a large placenta-derived glycoprotein ... concentrations by placental trophoblast cells, and ... in increasing concentrations throughout gestation until ... to pregnancy since measurable levels have ...
Medicine Products: